查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018621

人工智慧在醫學影像領域的市場：按組件、影像技術、應用和最終用戶分類－2026-2032年全球市場預測

Artificial Intelligence in Medical Imaging Market by Component, Imaging Technology, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年，醫學影像領域的人工智慧 (AI) 市場價值為 28.7 億美元，預計到 2026 年將成長至 36.7 億美元，複合年成長率為 28.79%，到 2032 年將達到 169.1 億美元。

主要市場統計數據
基準年 2025 28.7億美元
預計年份：2026年 36.7億美元
預測年份 2032 169.1億美元
複合年成長率 (%) 28.79%

在醫學影像領域策略性地應用人工智慧，將其定位為臨床轉型、加速研究和提高營運效率的催化劑。

人工智慧在醫學影像領域的應用已從一個充滿前景的研究方向發展成為提升診斷準確性、實現工作流程自動化和增強臨床決策支援的關鍵基礎。這項發展說明了為何人工智慧驅動的影像解決方案不再是邊緣實驗，而是現代醫療服務的核心要素。演算法效能的提升、計算資源的增強以及豐富影像資料集的積累，使得研究階段的原型能夠迅速實用化臨床實用工具，從而輔助放射科醫生的工作、支持多學科團隊協作並簡化行政管理任務。

新的人工智慧範式如何重塑整個醫療保健領域的診斷工作流程、影像解讀和臨床決策，從而為營運帶來巨大變化。

近年來，醫學影像的採集、處理和解讀方式發生了變革性的變化。其中一項根本性的變化是深度學習架構的成熟，使其在病灶檢測、量化和分診優先排序等任務中展現出具有臨床意義的表現。隨著演算法變得更加穩健，資料密集型方法能夠獲得更大、更精心整理的資料集，臨床接受度也在不斷提高，使得醫療專業人員能夠將人工智慧的輸出結果整合到診斷工作流程中，作為決策支援而非黑箱結論。

評估美國關稅政策在 2025 年對全球醫療影像供應鏈、籌資策略和醫療設備定價趨勢的累積影響。

2025年的關稅環境將為整個醫療影像生態系統中的供應商、買家和整合商帶來更大的複雜性。進口關稅和跨境貿易政策的變化正在對供應鏈策略、採購決策以及使用醫療影像硬體和軟體的解決方案的總擁有成本產生連鎖反應。供應商和醫療系統正在重新思考其籌資策略，以減輕關稅相關成本波動的影響，同時確保獲得關鍵技術。

基於細分的關鍵見解揭示了元件、成像技術、應用程式和最終用戶的差異如何影響部署路徑和解決方案策略。

為了解部署模式和商業化路徑，必須仔細分析市場如何按組件、成像技術、應用和最終用戶進行細分。組件細分區分硬體、軟體和服務，服務進一步細分為託管服務和專業服務。這種區分明確了哪些參與者在創造經常性收入，哪些參與者專注於銷售資本設備。影像技術細分區分CT掃描儀、MRI系統、超音波設備和X光系統。每種設備都有其獨特的整合挑戰、臨床工作流程和監管要求，這些都會影響人工智慧開發的優先順序。

美洲、歐洲、中東和非洲以及亞太地區招募、監管和夥伴關係生態系統的區域趨勢和策略細微差別。

區域趨勢正深刻影響人工智慧在醫學影像領域的應用軌跡，導致美洲、歐洲、中東、非洲和亞太地區在監管環境、報銷機制和夥伴關係方面存在差異。在美洲，創新中心和早期採用人工智慧的醫療保健系統正在加速概念驗證（PoC）專案的部署，而複雜的支付方環境則強調了證明臨床和經濟價值的證據的重要性。該地區的監管流程優先考慮安全性和有效性，跨境合作通常專注於數據協調，以進行多中心檢驗。

深入了解企業層面的競爭與合作，並專注於領先的醫療技術和人工智慧公司的創新策略、夥伴關係模式和技術融合。

醫療影像人工智慧領域的企業級發展趨勢反映了競爭差異化與協作生態系統的融合。主要企業正採用多管齊下的策略，結合內部演算法開發、與影像設備製造商的合作以及與臨床網路的協作，以加速檢驗和市場滲透。創新策略通常強調基於平台的方法，支援跨模態的模組化分析，使供應商能夠提供整合硬體、軟體和託管服務的捆綁式解決方案。

為行業領導者提供可操作的建議，以加速安全人工智慧整合、最佳化採購並增強臨床和商業性價值提案。

產業領導者必須採取果斷行動，將技術潛力轉化為永續的臨床和商業性價值。首先，各機構應優先進行嚴格的臨床檢驗，使績效指標與真實世界的臨床終點和臨床醫師的工作流程相符。這能確保人工智慧的輸出在臨床實務中實用可靠。投資前瞻性研究、多中心試驗和實施後監測，將有助於贏得保險公司、監管機構和臨床醫生的信任。

嚴謹的調查方法，說明了用於得出基於證據的結論的資料來源、分析框架、檢驗協議和相關人員參與。

本研究採用多方面方法，結合與關鍵相關人員的對話、二手資訊的檢驗以及系統性的分析框架，以確保研究結果的穩健性和相關性。關鍵資訊輸入包括對臨床醫生、放射科醫生、採購經理和技術主管的結構化訪談，從而獲得關於臨床效用、營運限制和採購動機的第一手觀點。二手分析則利用同行評審文獻、監管指導文件和公開的臨床檢驗研究來支持​​研究結論並追蹤臨床影響的證據。

這份權威總結整合了技術、監管、商業和臨床等方面的內容，清楚地為整個生態系統中的相關人員提供了切實可行的見解。

總之，人工智慧正從技術、營運和商業性角度變革醫學影像診斷。演算法能力的進步及其與影像平台的整合，催生了新的診斷工作流程並提高了效率。同時，監管的日趨成熟以及保險公司的嚴格審查，正促使供應商將工作重點轉向透明的檢驗和可衡量的臨床價值。組件、模式、應用和終端用戶群體之間的相互作用表明，單一方法無法滿足所有市場的需求。相反，針對學術研究中心、診斷機構和醫院的特定需求量身定做的策略，最有可能實現永續的普及應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：醫療影像人工智慧市場：按組件分類

  • 硬體
  • 服務
    • 託管服務
    • 專業服務
  • 軟體

第9章：醫學影像人工智慧市場：依診斷影像技術分類

  • CT掃描儀
  • 磁振造影系統
  • 超音波診斷設備
  • X光系統

第10章：人工智慧在醫學影像領域的市場：按應用分類

  • 循環系統
  • 神經病學
  • 腫瘤學
  • 病理
  • 放射科

第11章：醫學影像人工智慧市場：按最終用戶分類

  • 學術和研究機構
  • 診斷中心
  • 醫院和診所

第12章：人工智慧在醫學影像領域的市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：醫學影像人工智慧市場：按類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：人工智慧在醫學影像領域的市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國醫療影像領域的人工智慧市場

第16章：中國醫學影像人工智慧市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • aetherAI
  • Agfa-Gevaert Group
  • Behold.ai Technologies Limited
  • Brainomix Limited
  • Butterfly Network, Inc.
  • Cancer Center.ai
  • CureMetrix, Inc.
  • Dr CADx
  • EchoNous, Inc.
  • Enlitic, Inc.
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Intelerad Medical Systems Incorporated
  • Koninklijke Philips NV
  • Nano-X Imaging Ltd.
  • Nuance Communications, Inc.
  • NVIDIA Corporation
  • RetinAI
  • Shanghai United Imaging Healthcare Co., LTD
  • Siemens Healthineers AG
  • SigTuple Technologies Private Limited.
  • Subtle Medical
  • Tempus AI, Inc
  • Volpara Health Technologies Ltd.
  • Brainminer Ltd
Product Code: MRR-221461476A09

The Artificial Intelligence in Medical Imaging Market was valued at USD 2.87 billion in 2025 and is projected to grow to USD 3.67 billion in 2026, with a CAGR of 28.79%, reaching USD 16.91 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.87 billion
Estimated Year [2026] USD 3.67 billion
Forecast Year [2032] USD 16.91 billion
CAGR (%) 28.79%

A strategic introduction that frames artificial intelligence in medical imaging as a catalyst for clinical transformation, research acceleration, and operational efficiency

Artificial intelligence in medical imaging has evolved from a promising research area into a critical enabler of diagnostic precision, workflow automation, and clinical decision support. This introduction sets the context for why AI-driven imaging solutions are no longer peripheral experiments but central components of modern care delivery. Advances in algorithmic performance, combined with improved computational resources and richer image datasets, have accelerated the translation of research prototypes into clinically relevant tools that augment radiologists, support multidisciplinary teams, and streamline administrative processes.

As care providers contend with growing imaging volumes, workforce shortages, and pressure to deliver value-based outcomes, AI offers tangible levers to enhance throughput and interpretive consistency while reducing time-to-diagnosis. At the same time, the intersection of imaging hardware, software algorithms, and services is creating new business models that span device manufacturers, software vendors, and service integrators. These convergences introduce both opportunities and complexities: while integration promises better end-to-end solutions, it also heightens the importance of interoperability, data governance, and rigorous clinical validation.

In this landscape, stakeholders must balance technical performance with regulatory compliance and clinical utility. Therefore, strategic planning for AI adoption requires not only technical appraisal but also operational readiness, workflow redesign, and stakeholder engagement. This executive summary will synthesize technological trends, policy influences, segmentation implications, regional dynamics, and company-level strategies to support informed decision-making across clinical, commercial, and policy domains.

How emerging AI paradigms are reshaping diagnostic workflows, image interpretation, and clinical decision-making across care settings with profound operational shifts

The last several years have witnessed transformative shifts that are redefining how medical images are acquired, processed, and interpreted. One fundamental change is the maturation of deep learning architectures that deliver clinically meaningful performance for tasks such as lesion detection, quantification, and triage prioritization. As algorithms become more robust and data-hungry approaches find access to larger curated datasets, clinical acceptance has increased, enabling practitioners to incorporate AI outputs into diagnostic workflows as decision support rather than black-box conclusions.

Concurrently, the integration of AI into imaging hardware and enterprise systems is changing procurement and operational models. Imaging devices are increasingly offered with embedded analytics, subscription-based software, and optional managed services that shift capital expenditures toward operational expenditure frameworks. This shift is accompanied by a growing emphasis on end-to-end interoperability: AI tools must integrate seamlessly with picture archiving and communication systems, electronic health records, and reporting platforms to preserve continuity of care.

Another pivotal shift is regulatory evolution. Regulators are developing frameworks for algorithm transparency, performance monitoring, and post-market surveillance, which in turn shapes vendor roadmaps and health system adoption strategies. Moreover, collaborative models between clinicians, data scientists, and vendors are becoming the norm, supporting iterative validation and local calibration of AI models. Taken together, these shifts accelerate clinical integration while underscoring the need for robust governance, transparent validation, and investment in clinical change management.

Evaluating the cumulative effects of United States tariff policies in 2025 on global medical imaging supply chains, procurement strategies, and device pricing dynamics

The tariff environment in 2025 has introduced additional layers of complexity for suppliers, purchasers, and integrators across the medical imaging ecosystem. Changes in import duties and cross-border trade policies have a cascading influence on supply chain strategies, sourcing decisions, and the total cost of ownership for imaging hardware and software-enabled solutions. Vendors and health systems are recalibrating procurement strategies to mitigate exposure to tariff-driven cost fluctuations while maintaining access to critical technologies.

In response to tariff pressures, many suppliers are accelerating diversification of manufacturing and component sourcing. Where feasible, production is relocated or expanded across multiple jurisdictions to reduce reliance on a single supply corridor and to preserve price stability. This geographic redistribution can lengthen supply chains in the near term while introducing resilience benefits over time. Simultaneously, procurement teams are renegotiating contract terms to reflect tariff contingencies and to secure more flexible maintenance and upgrade arrangements that limit capital risk.

Tariffs also influence partnership strategies: vendors increasingly explore local partnerships, licensing arrangements, and co-development agreements to penetrate tariff-sensitive markets. For clinical operators, strategic inventory management and stronger vendor-service relationships become essential to ensure uptime and continuity of care. Ultimately, while tariffs introduce short-term cost and logistical challenges, they are also catalyzing structural adjustments that prioritize supply chain resilience, local collaboration, and smarter procurement frameworks across the sector.

Key segmentation-driven insights revealing how component, imaging technology, application, and end-user distinctions influence adoption pathways and solution strategies

Understanding adoption patterns and commercialization pathways requires close attention to how the market is segmented along component, imaging technology, application, and end-user dimensions. Component segmentation differentiates hardware from software and services, with services further subdivided into managed and professional offerings, and this split clarifies which players derive recurring revenue versus those focused on capital equipment sales. Imaging technology segmentation distinguishes CT scanners, MRI systems, ultrasound devices, and X-ray systems, each with distinct integration challenges, clinical workflows, and regulatory expectations that influence AI development priorities.

Application segmentation reveals where clinical demand for AI is most concentrated: cardiology and neurology use cases often require high temporal and spatial fidelity and benefit from specialized analytics; oncology and radiology applications demand robust lesion detection and characterization; pathology-driven image analysis is advancing as digitization of slides accelerates. End-user segmentation highlights differing procurement cycles and adoption drivers among academic and research institutions, diagnostic centers, and hospitals and clinics. Academic centers frequently drive early validation and complex use cases, diagnostic centers emphasize throughput and turn-around time efficiencies, and hospitals and clinics prioritize interoperability, vendor support, and integration into broader care pathways.

These segmentation lenses are essential for vendors and health systems to match product design, service models, and validation strategies to the specific needs of each buyer cohort. Consequently, segmentation-aware planning enables more precise go-to-market approaches, targeted clinical studies, and differentiated support services that increase adoption likelihood and clinical impact.

Regional dynamics and strategic nuances across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape adoption, regulation, and partnership ecosystems

Regional dynamics profoundly shape the trajectory of AI adoption in medical imaging, producing divergent regulatory, reimbursement, and partnership landscapes across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, innovation hubs and early-adopter health systems accelerate proof-of-concept deployments, while a complex payer environment underscores the importance of evidence demonstrating clinical and economic value. Regulatory pathways in this region emphasize safety and efficacy, and cross-border collaborations often focus on data harmonization for multi-center validation.

In Europe Middle East & Africa, the regulatory mosaic introduces both constraints and incentives for adoption. Europe's evolving regulatory standards demand transparency and post-market vigilance, prompting vendors to emphasize explainability and real-world performance monitoring. In the Middle East and Africa, growth opportunities are shaped by investment in imaging infrastructure and strategic partnerships that can leapfrog traditional adoption curves, but success depends on local capacity-building and workforce training.

The Asia-Pacific region is characterized by rapid infrastructure expansion, large population-scale datasets, and proactive government initiatives to digitize healthcare. These factors create fertile ground for accelerated deployment of AI-enabled imaging solutions, though local regulatory and data sovereignty considerations necessitate careful compliance strategies. Across all regions, successful market entry combines clinical validation, regulatory alignment, and culturally attuned commercialization plans that reflect local care delivery models and reimbursement realities.

Competitive and collaborative company-level insights highlighting innovation strategies, partnership models, and technology convergence among leading medtech and AI firms

Company-level dynamics in the medical imaging AI space reflect a blend of competitive differentiation and collaborative ecosystems. Leading organizations deploy multi-pronged strategies that combine in-house algorithm development, partnerships with imaging device manufacturers, and alliances with clinical networks to accelerate validation and market reach. Innovation strategies often emphasize platform approaches that support modular analytics across modalities, enabling vendors to offer bundled solutions that integrate hardware, software, and managed services.

Strategic partnerships are increasingly common as companies recognize the value of combining algorithmic expertise with clinical domain knowledge and imaging hardware capabilities. Co-development agreements with clinical sites expedite access to annotated datasets and facilitate real-world performance assessments. Meanwhile, service-oriented models-particularly managed services-allow vendors to provide continuous optimization, model maintenance, and performance monitoring, enhancing long-term customer value and differentiation.

Mergers, acquisitions, and licensing arrangements remain a core route to scale, especially for firms seeking rapid access to complementary technologies or geographic markets. At the same time, emphasis on ethical AI practices, transparent validation, and robust post-market surveillance is becoming a competitive requirement, not just a regulatory checkbox. In this environment, companies that combine credible clinical evidence, scalable deployment models, and strong customer support will be best positioned to capture value and sustain adoption over time.

Actionable recommendations for industry leaders to accelerate safe AI integration, optimize procurement, and strengthen clinical and commercial value propositions

Industry leaders must take decisive steps to translate technological promise into sustained clinical and commercial value. First, organizations should prioritize rigorous clinical validation that aligns performance metrics with real-world endpoints and clinician workflows, thereby ensuring that AI outputs are actionable and trusted at the point of care. Investing in prospective studies, multi-center trials, and post-deployment monitoring will build credibility with payers, regulators, and clinicians alike.

Second, companies should design interoperable solutions that integrate smoothly with existing imaging modalities, hospital information systems, and cloud or on-premises infrastructures. Interoperability reduces friction during deployment and supports scalable rollouts across heterogeneous IT environments. Third, operational readiness is essential: leadership should allocate resources for clinician training, change management, and continuous model governance to maintain performance and address drift over time.

Fourth, supply chain and procurement strategies must incorporate contingency planning for tariff and trade disruptions, emphasizing diversified sourcing and local partnerships where appropriate. Fifth, ethical and regulatory compliance should be embedded from product design through post-market surveillance, with transparent reporting of limitations and performance. Finally, leaders should explore commercial models that balance upfront capital with subscription and managed services to align incentives and sustain long-term relationships with customers. Collectively, these actions will accelerate safe adoption and create durable competitive advantage.

A rigorous research methodology describing data sources, analytical frameworks, validation protocols, and stakeholder engagement used to ensure evidence-based conclusions

This research synthesis is grounded in a multi-method approach that combines primary stakeholder engagement, secondary source triangulation, and systematic analytical frameworks to ensure robustness and relevance. Primary inputs include structured interviews with clinicians, imaging technicians, procurement leaders, and technology executives, providing firsthand perspectives on clinical utility, operational constraints, and purchase drivers. Secondary analysis draws on peer-reviewed literature, regulatory guidance documents, and publicly available clinical validation studies to corroborate claims and trace evidence of clinical impact.

Analytical frameworks employed in the study include modality-specific evaluation matrices, risk and compliance assessments, and integration readiness scoring to compare solutions across technical, clinical, and operational dimensions. Data validation protocols encompass cross-verification of reported performance metrics with independent studies and examination of post-market surveillance mechanisms where available. Stakeholder engagement protocols ensure that diverse geographic and care-setting perspectives are represented, enabling a nuanced understanding of regional and end-user variations.

To enhance transparency, the methodology documents assumptions, inclusion criteria, and limitations, and it outlines how qualitative insights were synthesized with quantitative indicators. Sensitivity analyses were applied where appropriate to test the robustness of comparative judgments. This methodological rigor supports confidence in the conclusions and provides a replicable foundation for subsequent updates and extensions.

A conclusive synthesis drawing together technological, regulatory, commercial, and clinical threads to articulate practical implications for stakeholders across the ecosystem

In conclusion, artificial intelligence is reshaping medical imaging across technological, operational, and commercial dimensions. Advances in algorithmic capability and integration into imaging platforms are enabling new diagnostic workflows and efficiency gains, while regulatory maturation and payor scrutiny are redirecting vendor priorities toward transparent validation and measurable clinical value. The interplay of component, modality, application, and end-user segmentation highlights that no single approach will fit all markets; instead, tailored strategies that reflect the specific needs of academic research centers, diagnostic facilities, and hospitals yield the highest probability of sustained adoption.

Regionally, the market is characterized by differentiated adoption drivers and regulatory expectations, with each geography offering unique opportunities and constraints. Tariff dynamics in 2025 are introducing supply chain complexity but are also incentivizing more resilient procurement and localized partnerships. At the company level, the most successful organizations will be those that combine rigorous clinical evidence, interoperability, scalable service models, and strong post-market governance.

Ultimately, the path forward requires coordinated action across vendors, clinicians, payers, and regulators to ensure that AI-enabled imaging technologies deliver measurable improvements in diagnostic accuracy, workflow efficiency, and patient outcomes. By aligning technological innovation with clinical needs and robust governance, stakeholders can realize the full potential of AI while managing risk and fostering sustainable adoption across diverse healthcare systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Intelligence in Medical Imaging Market, by Component

  • 8.1. Hardware
  • 8.2. Services
    • 8.2.1. Managed Services
    • 8.2.2. Professional Services
  • 8.3. Software

9. Artificial Intelligence in Medical Imaging Market, by Imaging Technology

  • 9.1. CT Scanners
  • 9.2. MRI Systems
  • 9.3. Ultrasound Devices
  • 9.4. X-ray Systems

10. Artificial Intelligence in Medical Imaging Market, by Application

  • 10.1. Cardiology
  • 10.2. Neurology
  • 10.3. Oncology
  • 10.4. Pathology
  • 10.5. Radiology

11. Artificial Intelligence in Medical Imaging Market, by End-User

  • 11.1. Academic & Research Institutions
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals & Clinics

12. Artificial Intelligence in Medical Imaging Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Artificial Intelligence in Medical Imaging Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Artificial Intelligence in Medical Imaging Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Artificial Intelligence in Medical Imaging Market

16. China Artificial Intelligence in Medical Imaging Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. aetherAI
  • 17.6. Agfa-Gevaert Group
  • 17.7. Behold.ai Technologies Limited
  • 17.8. Brainomix Limited
  • 17.9. Butterfly Network, Inc.
  • 17.10. Cancer Center.ai
  • 17.11. CureMetrix, Inc.
  • 17.12. Dr CADx
  • 17.13. EchoNous, Inc.
  • 17.14. Enlitic, Inc.
  • 17.15. Fujifilm Holdings Corporation
  • 17.16. GE Healthcare
  • 17.17. Intelerad Medical Systems Incorporated
  • 17.18. Koninklijke Philips N.V.
  • 17.19. Nano-X Imaging Ltd.
  • 17.20. Nuance Communications, Inc.
  • 17.21. NVIDIA Corporation
  • 17.22. RetinAI
  • 17.23. Shanghai United Imaging Healthcare Co., LTD
  • 17.24. Siemens Healthineers AG
  • 17.25. SigTuple Technologies Private Limited.
  • 17.26. Subtle Medical
  • 17.27. Tempus AI, Inc
  • 17.28. Volpara Health Technologies Ltd.
  • 17.29. Brainminer Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY IMAGING TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY PROFESSIONAL SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY PROFESSIONAL SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY PROFESSIONAL SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY CT SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY CT SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY CT SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY MRI SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY MRI SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY MRI SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY X-RAY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY X-RAY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY X-RAY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY PATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY PATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY PATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 114. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 116. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 117. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. GCC ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 132. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 134. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 135. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. G7 ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 138. NATO ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. NATO ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 140. NATO ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 141. NATO ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. NATO ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. NATO ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 154. CHINA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA ARTIFICIAL INTELLIGENCE IN MEDICAL IMAGING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)